PetDx

PetDx, Inc. is a molecular diagnostics company located in San Diego, dedicated to unleashing the power of genomics to improve pet health. PetDx™ is a team of veterinarians, scientists, and business leaders committed to revolutionizing the early detection of cancer in pets. Our non-invasive cancer detection solutions incorporate many of the latest advancements in the field of liquid biopsy for humans. The company’s flagship product, OncoK9™, enables veterinarians to detect cancer in dogs through a simple blood draw. As a first-class multi-cancer early detection (MCED) test, OncoK9 utilizes cutting-edge genomic analysis, leveraging next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms, allowing veterinarians to provide high-quality care for their canine patients.